ZA989514B - Treatment of diabetic retinopathy - Google Patents

Treatment of diabetic retinopathy

Info

Publication number
ZA989514B
ZA989514B ZA989514A ZA989514A ZA989514B ZA 989514 B ZA989514 B ZA 989514B ZA 989514 A ZA989514 A ZA 989514A ZA 989514 A ZA989514 A ZA 989514A ZA 989514 B ZA989514 B ZA 989514B
Authority
ZA
South Africa
Prior art keywords
treatment
diabetic retinopathy
retinopathy
diabetic
Prior art date
Application number
ZA989514A
Other languages
English (en)
Inventor
Louis Desantis Jr
Original Assignee
Alcon Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Lab Inc filed Critical Alcon Lab Inc
Publication of ZA989514B publication Critical patent/ZA989514B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA989514A 1997-11-14 1998-10-19 Treatment of diabetic retinopathy ZA989514B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6569497P 1997-11-14 1997-11-14

Publications (1)

Publication Number Publication Date
ZA989514B true ZA989514B (en) 1999-06-15

Family

ID=22064483

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA989514A ZA989514B (en) 1997-11-14 1998-10-19 Treatment of diabetic retinopathy

Country Status (4)

Country Link
AR (1) AR013749A1 (xx)
AU (1) AU9797598A (xx)
WO (1) WO1999025350A1 (xx)
ZA (1) ZA989514B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050009884A1 (en) * 1997-06-30 2005-01-13 Dreyer Evan B. Calcium blockers to treat proliferative retinal diseases
BRPI0513862A (pt) * 2004-07-26 2008-05-20 Allergan Inc métodos de tratar condições oftálmicas
US20070203144A1 (en) * 2006-01-17 2007-08-30 Allergan, Inc. Use of Memantine and Brimonidine to Attenuate Vitreoretinal Vascular Endothelial Growth Factor (VEGF) Protein Levels in Animals
WO2011112243A2 (en) * 2010-03-08 2011-09-15 The University Of Tennessee Research Foundation Beta -adrenergic receptor agonists and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990006118A1 (en) * 1988-12-05 1990-06-14 Houston Biotechnology Incorporated Therapeutic use of dihydropyrimidones and benzazepine and benzothiazepine derivatives in retinal or optic nerve dysfunction
US5521215A (en) * 1989-11-07 1996-05-28 Ramot University Authority For Applied Research And Industrial Development Ltd. NMDA-blocking pharmaceuticals
US5856329A (en) * 1995-06-28 1999-01-05 Allergan Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury
FR2738568B1 (fr) * 1995-09-08 1997-10-17 Synthelabo Derives de 4-(cycloalkyl)piperidines et 4-(cycloalkylalkyl) piperidines, leur preparation et leur application en therapeutique
WO1997038691A1 (fr) * 1996-04-17 1997-10-23 Sumitomo Pharmaceuticals Co., Ltd. Medicament pour neuropathie retinienne

Also Published As

Publication number Publication date
AR013749A1 (es) 2001-01-10
AU9797598A (en) 1999-06-07
WO1999025350A1 (en) 1999-05-27

Similar Documents

Publication Publication Date Title
AU9040098A (en) Compounds and method for the prevention and treatment of diabetic retinopathy
PL337362A1 (en) Treatment of diabetes by means of thiazolydinone and metformin
ZA96740B (en) Skin treatment composition
IL135867A0 (en) Disposable underpants
EG21712A (en) Treatment of insulin resistance
PL336760A1 (en) Treatment of skin diseases
PL337510A1 (en) Treatment of diabetes by means of derivatives of thiazolydinone and sulphonylurea
GB9606076D0 (en) Diabetes treatment
ZA989514B (en) Treatment of diabetic retinopathy
GB2303303B (en) Medical treatment
GB9521725D0 (en) Medical treatment
GB9704174D0 (en) Agent for medical treatment
GB9526264D0 (en) Medical treatment
GB2327431B (en) Treatment of fabrics
GB9618290D0 (en) Treatment of diabetes
GB9721978D0 (en) Treatment of depression
GB9609897D0 (en) Treatment of diabetes
GB9815149D0 (en) Treatment of diabetes
GB9812314D0 (en) Treatment of diabetes
GB9726745D0 (en) Treatment of medical conditions
GB9710054D0 (en) Treatment of diseases
GB9710544D0 (en) Medical treatment
HUP0103568A3 (en) Treatment of depression
GB9708700D0 (en) Treatment of depression
ZA982994B (en) Therapeutic treatment